You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TMC207

Showing 1 - 25 of 60
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leprosy, Multibacillary Trial in Bauru, Manaus (Bedaquiline 200 mg)

Active, not recruiting
  • Leprosy, Multibacillary
  • Bedaquiline 200 mg
  • Bauru, Brazil
  • +1 more
Aug 2, 2022

Tuberculosis, HIV Trial in United States (Efavirenz (EFV), TMC207)

Completed
  • Tuberculosis
  • HIV
  • Efavirenz (EFV)
  • TMC207
  • San Francisco, California
  • +4 more
Oct 28, 2021

Pulmonary TB, Pulmonary Tuberculosis, Drug Sensitive Tuberculosis Trial in Worldwide (TBAJ-876, Pretomanid, Linezolid)

Not yet recruiting
  • Pulmonary TB
  • +2 more
  • Tbilisi, Georgia
  • +20 more
Sep 22, 2023

Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • +5 more
  • Bedaquiline 100 MG
  • +4 more
  • Pune, India
  • +9 more
Mar 2, 2022

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,

Active, not recruiting
  • Tuberculosis, Pulmonary
  • +5 more
  • Tbilisi, Georgia
  • +10 more
Jan 26, 2022

Multidrug Resistant Tuberculosis Trial in Belarus, South Africa, Uzbekistan (Bedaquiline, Pretomanid, Moxifloxacin)

Recruiting
  • Multidrug Resistant Tuberculosis
  • Minsk, Belarus
  • +5 more
May 12, 2021

Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis Trial in Belarus, South

Active, not recruiting
  • Multi-drug Resistant Tuberculosis
  • +2 more
  • Minsk, Belarus
  • +4 more
May 12, 2021

Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculoses Trial in Belarus, South

Recruiting
  • Multi-drug Resistant Tuberculosis
  • +2 more
  • Minsk, Belarus
  • +6 more
May 12, 2021

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

Completed
  • Tuberculosis, Pulmonary
  • +4 more
  • Rio de Janeiro, Brazil
  • +25 more
Jun 23, 2022

Pulmonary Tuberculosis Trial in Ysterplaat, Sydenham, Sandringham (Bedaquiline, PA-824, Linezolid)

Completed
  • Pulmonary Tuberculosis
  • Ysterplaat, Cape Town, South Africa
  • +2 more
Nov 19, 2020

Tuberculosis, Multidrug-Resistant Trial in Kiyose, Sakai (TMC207 (bedaquiline), Background Regimen (BR))

Completed
  • Tuberculosis, Multidrug-Resistant
  • TMC207 (bedaquiline)
  • Background Regimen (BR)
  • Kiyose, Japan
  • +1 more
Oct 30, 2019

Tuberculosis Trial in Lincoln (TMC207, rifapentine, rifampicin)

Completed
  • Tuberculosis
  • TMC207
  • +2 more
  • Lincoln, Nebraska
    Celerion (MDS Pharma Services)
Sep 4, 2019

Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Pulmonary Trial in Belarus, South

Active, not recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Minsk, Belarus
  • +6 more
May 12, 2021

Healthy Trial in Antwerpen (Bedaquiline (Test formulation), Bedaquiline (Reference formulation))

Completed
  • Healthy
  • Bedaquiline (Test formulation)
  • Bedaquiline (Reference formulation)
  • Antwerpen, Belgium
    SGS Life Science Services
Jan 21, 2020

Tuberculosis Trial in South Africa, Tanzania, Uganda (PA-824, bedaquiline, moxifloxacin)

Completed
Has Results
  • Tuberculosis
  • Tembisa, Gauteng, South Africa
  • +9 more
May 28, 2019

MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)

Active, not recruiting
  • MDR-TB
  • Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
  • +9 more
  • Addis Ababa, Ethiopia
  • +12 more
Oct 12, 2022

Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

Active, not recruiting
  • Tuberculosis
  • +4 more
  • Bedaquiline Oral Tablet
  • +7 more
  • Port Elizabeth, Eastern Cape, South Africa
  • +1 more
Oct 20, 2022

Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Trial in Japan (Bedaquiline, Clarithromycin, Ethambutol)

Recruiting
  • Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
  • Aichi, Japan
  • +42 more
Jan 17, 2023

Tuberculosis Trial in Lithuania, Russian Federation (TMC207)

Approved for marketing
  • Tuberculosis
  • TMC207
  • Vilnius, Lithuania
  • +4 more
Nov 23, 2017

Pharmacometrics to Advance Novel Regimens for Drug-resistant

Recruiting
  • Multi-drug Resistant Tuberculosis
    • Almaty, Kazakhstan
    • +6 more
    Nov 1, 2022

    Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in United States (coagulation factor VIIa [recombinant]-jncw)

    Recruiting
    • Hemophilia A With Inhibitor
    • Hemophilia B With Inhibitor
    • coagulation factor VIIa [recombinant]-jncw
    • Phoenix, Arizona
    • +23 more
    Aug 10, 2022

    ATHN 11: Liver Transplantation Outcomes Study

    Recruiting
    • Hemophilia A and B
    • Liver Transplantation
      • Los Angeles, California
      • +14 more
      Feb 14, 2022

      Multi Drug Resistant Tuberculosis, HIV Trial in Durban (Adherence support intevention)

      Not yet recruiting
      • Multi Drug Resistant Tuberculosis
      • HIV Infections
      • Adherence support intevention
      • Durban, KwaZulu-Natal, South Africa
        King DinuZulu Hospital
      Nov 21, 2022

      Study of Multidrug-Resistant Patient Outcomes With and Without

      Recruiting
      • HIV Infections
      • Multi-Antiviral Resistance
      • No ibalizumab or Pre-ibalizumab treatment
      • On ibalizumab treatment
      • Los Angeles, California
      • +38 more
      Jan 31, 2023

      Parkinson Disease Trial in Worldwide (Tavapadon, Placebo)

      Recruiting
      • Parkinson Disease
      • Phoenix, Arizona
      • +145 more
      Dec 20, 2022